All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Ono Pharmaceutical Co., Ltd. revenue reports

Ono Pharmaceutical Co., Ltd. financial reports, Ono Pharmaceutical Co., Ltd. annual revenue in 2022. When does Ono Pharmaceutical Co., Ltd. report revenue?
Add to widgets
Added to widgets

Ono Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in Euro today

Ono Pharmaceutical Co., Ltd. current income and income for the latest reporting periods. The dynamics of Ono Pharmaceutical Co., Ltd. net revenue grew by 13 012 000 000 € compared to the previous report. Net income, revenue and dynamics - the main financial indicators of Ono Pharmaceutical Co., Ltd.. The financial report chart on our website displays information by dates from 31/03/2019 to 30/06/2021. The value of the "total revenue of Ono Pharmaceutical Co., Ltd." on the chart is marked in yellow. The value of all Ono Pharmaceutical Co., Ltd. assets on the graph is shown in green.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 76 939 196 292 € +18.09 % ↑ 21 201 586 616 € +47.42 % ↑
31/03/2021 65 479 736 084 € +13.62 % ↑ 7 871 553 592 € +6.33 % ↑
31/12/2020 74 381 689 956 € +10.71 % ↑ 23 459 660 392 € +40.12 % ↑
30/09/2020 66 545 363 724 € +0.71 % ↑ 16 163 193 452 € +11.32 % ↑
31/12/2019 67 188 263 044 € - 16 742 683 524 € -
30/09/2019 66 074 197 784 € - 14 518 956 424 € -
30/06/2019 65 154 763 688 € - 14 381 569 720 € -
31/03/2019 57 629 318 908 € - 7 403 029 704 € -
Show:
to

Ono Pharmaceutical Co., Ltd. financial report charts

The dates of the latest financial statements of Ono Pharmaceutical Co., Ltd.: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Ono Pharmaceutical Co., Ltd. for today is 30/06/2021. Gross profit Ono Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Ono Pharmaceutical Co., Ltd. is 64 564 000 000 €

Ono Pharmaceutical Co., Ltd. quarterly report dates

Cost of revenue Ono Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Ono Pharmaceutical Co., Ltd. is 22 799 000 000 € Total revenue Ono Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Ono Pharmaceutical Co., Ltd. is 87 363 000 000 € Operating income Ono Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Ono Pharmaceutical Co., Ltd. is 29 792 000 000 €

Net income Ono Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Ono Pharmaceutical Co., Ltd. is 24 074 000 000 € Current assets Ono Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Ono Pharmaceutical Co., Ltd. is 243 671 000 000 € Total assets Ono Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Ono Pharmaceutical Co., Ltd. is 742 873 000 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
56 860 481 776 € 48 375 091 436 € 52 900 926 512 € 47 877 504 976 € 49 674 100 336 € 47 634 436 192 € 46 898 184 368 € 42 448 968 800 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
20 078 714 516 € 17 104 644 648 € 21 480 763 444 € 18 667 858 748 € 17 514 162 708 € 18 439 761 592 € 18 256 579 320 € 15 180 350 108 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
76 939 196 292 € 65 479 736 084 € 74 381 689 956 € 66 545 363 724 € 67 188 263 044 € 66 074 197 784 € 65 154 763 688 € 57 629 318 908 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
26 237 337 728 € 14 562 109 940 € 26 233 814 992 € 22 332 384 872 € 21 283 490 228 € 19 284 337 548 € 17 596 066 320 € 10 068 860 172 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
21 201 586 616 € 7 871 553 592 € 23 459 660 392 € 16 163 193 452 € 16 742 683 524 € 14 518 956 424 € 14 381 569 720 € 7 403 029 704 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
13 426 027 580 € 16 325 239 308 € 15 951 829 292 € 11 792 358 760 € 12 713 554 224 € 13 182 958 796 € 14 061 000 744 € 16 588 563 824 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
50 701 858 564 € 50 917 626 144 € 48 147 874 964 € 44 212 978 852 € 45 904 772 816 € 46 789 860 236 € 47 558 697 368 € 47 560 458 736 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
214 597 150 964 € 218 094 347 128 € 211 149 273 104 € 199 714 472 048 € 198 533 474 804 € 184 884 634 172 € 156 858 627 240 € 171 396 078 028 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
654 236 365 132 € 657 731 799 928 € 633 203 869 844 € 622 463 047 780 € 580 561 864 428 € 565 509 213 500 € 564 571 285 040 € 576 897 338 304 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
43 560 392 008 € 53 761 354 780 € 77 039 594 268 € 73 801 319 200 € 59 107 987 344 € 48 501 029 248 € 34 892 700 080 € 52 824 307 004 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 63 807 317 168 € 64 387 687 924 € 63 760 640 916 € 73 228 874 600 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 75 910 557 380 € 76 775 389 068 € 76 051 466 820 € 81 304 746 880 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 13.08 % 13.58 % 13.47 % 14.09 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
567 594 673 212 € 559 716 074 148 € 548 320 903 872 € 532 834 075 732 € 499 783 766 580 € 483 915 602 268 € 483 744 749 572 € 490 849 227 400 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 13 477 107 252 € 25 132 959 992 € 5 580 894 508 € 20 932 977 996 €

Last revenue report of Ono Pharmaceutical Co., Ltd. was 30/06/2021. According to last financial report total revenue in Ono Pharmaceutical Co., Ltd. was 76 939 196 292 Euro and changed by +18.09% since last year. Net income in Ono Pharmaceutical Co., Ltd. was 21 201 586 616 € in last quartal, net income changes to +47.42%.

Current cash Ono Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Ono Pharmaceutical Co., Ltd. is 49 462 000 000 €

Ono Pharmaceutical Co., Ltd. stocks data

Ono Pharmaceutical Co., Ltd. financials